These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30661641)

  • 21. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.
    Al Raiisi F; Stewart D; Fernandez-Llimos F; Salgado TM; Mohamed MF; Cunningham S
    Int J Clin Pharm; 2019 Jun; 41(3):630-666. PubMed ID: 30963447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of pharmacy services: a systematic review of the literature (2016-2020).
    Phimarn W; Saramunee K; Leelathanalerk A; Srimongkon P; Chanasopon S; Phumart P; Paktipat P; Babar ZU
    Int J Clin Pharm; 2023 Dec; 45(6):1326-1348. PubMed ID: 37233864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist-led medication review in community settings: An overview of systematic reviews.
    Jokanovic N; Tan EC; Sudhakaran S; Kirkpatrick CM; Dooley MJ; Ryan-Atwood TE; Bell JS
    Res Social Adm Pharm; 2017; 13(4):661-685. PubMed ID: 27665364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home treatment for mental health problems: a systematic review.
    Burns T; Knapp M; Catty J; Healey A; Henderson J; Watt H; Wright C
    Health Technol Assess; 2001; 5(15):1-139. PubMed ID: 11532236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature
    Hattingh HL; Scahill S; Fowler JL; Wheeler AJ
    J Ment Health; 2016 Dec; 25(6):550-559. PubMed ID: 26607639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of financial incentives on the quality of health care provided by primary care physicians.
    Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report.
    Garcia-Cardenas V; Benrimoj SI; Ocampo CC; Goyenechea E; Martinez-Martinez F; Gastelurrutia MA
    Res Social Adm Pharm; 2017; 13(3):614-627. PubMed ID: 27423785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Becoming 'indispensable': developing innovative community pharmacy practices.
    Willink DP; Isetts BJ
    J Am Pharm Assoc (2003); 2005; 45(3):376-86; quiz 387-9. PubMed ID: 15991760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumer willingness to pay for pharmacy services: An updated review of the literature.
    Painter JT; Gressler L; Kathe N; Slabaugh SL; Blumenschein K
    Res Social Adm Pharm; 2018 Dec; 14(12):1091-1105. PubMed ID: 29398405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis risk screening for women in a community pharmacy.
    Liu Y; Nevins JC; Carruthers KM; Doucette WR; McDonough RP; Pan X
    J Am Pharm Assoc (2003); 2007; 47(4):521-6. PubMed ID: 17616501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing the costs to deliver medication therapy management services.
    Rupp MT
    J Am Pharm Assoc (2003); 2011; 51(3):e19-26; quiz e27. PubMed ID: 21555277
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.